MYLUNG Consortium Part 3: Observational Study
Public ClinicalTrials.gov record NCT05885698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)
Study identification
- NCT ID
- NCT05885698
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- US Oncology Research
- Industry
- Enrollment
- 7,500 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 29, 2023
- Primary completion
- Nov 30, 2030
- Completion
- Nov 30, 2030
- Last update posted
- Jul 17, 2024
2023 – 2030
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center, PC | Daphne | Alabama | 36526 | Recruiting |
| Arizona Oncology Associates, PC - NAHOA | Prescott Valley | Arizona | 86314 | Not yet recruiting |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | Active, not recruiting |
| Cancer Care Centers of Brevard, Inc. | Palm Bay | Florida | 32901 | Recruiting |
| Woodlands Medical Specialists, PA | Pensacola | Florida | 32503 | Active, not recruiting |
| Affiliated Oncologists, LLC | Chicago Ridge | Illinois | 60415 | Recruiting |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | Active, not recruiting |
| Maryland Oncology Hematology, P.A. | Silver Spring | Maryland | 20904 | Active, not recruiting |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | Active, not recruiting |
| New York Oncology Hematology, P.C. | Albany | New York | 12208 | Recruiting |
| Oncology Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45242 | Recruiting |
| Willamette Valley Cancer Institute and Research Center | Eugene | Oregon | 97401 | Recruiting |
| Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care | Blacksburg | Virginia | 24060 | Recruiting |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | Active, not recruiting |
| Virginia Oncology Associates | Newport News | Virginia | 23606 | Recruiting |
| Shenandoah Oncology, P.C. | Winchester | Virginia | 22601 | Active, not recruiting |
| Northwest Cancer Specialists, P.C. | Vancouver | Washington | 98684 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05885698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2024 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05885698 live on ClinicalTrials.gov.